Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
239 hedge funds and large institutions have $3.4B invested in Inari Medical, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 109 increasing their positions, 65 reducing their positions, and 18 closing their positions.
78% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 18
68% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 65
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
12% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $10.4M
10% more capital invested
Capital invested by funds: $3.1B → $3.4B (+$301M)
5% more funds holding
Funds holding: 227 → 239 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$63.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$33.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$30M |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$22.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$20M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$97M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$32.8M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$26.6M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$17.9M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$16.2M |
NARI Hedge Fund Activity: Q3 2022 in Review
239 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q3 2022, worth a combined $3.4B — up 9.7% from $3.1B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new NARI positions and 18 closed out — a net gain of 14 holders — while 109 added to existing stakes and 65 trimmed.
The largest buyer was BlackRock, adding an estimated $63.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $97M.
- 239 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q3 2022, up from 227 in Q2 2022.
- Funds reported $3.4B of Inari Medical, Inc. Common Stock stock for Q3 2022, up 9.7% quarter-over-quarter.
- 32 funds opened new Inari Medical, Inc. Common Stock positions in Q3 2022 and 18 closed out, a net change of +14 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q3 2022 was BlackRock, an estimated $63.9M added.
- The largest Inari Medical, Inc. Common Stock seller in Q3 2022 was T. Rowe Price Associates, an estimated $97M sold.
Based on aggregated 13F filings for Q3 2022.